CyPep-1_product_DataBase

Bioactivity	CyPep-1 is a novel cationic lytic peptide with antitumor activity. CyPep-1 is highly cytotoxic by interacting with the negatively charged cell membrane of cancer cells. CyPep-1 has strong cytolytic activity on cancer cells both in vivo and in vitro, and can be used in the study of solid tumors[1].
Invitro	CyPep-1 (0-40 μg/mL；15-360 分钟) 以剂量和时间依赖的方式对肿瘤细胞系产生毒性，对正常细胞系影响较小[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> CyPep-1 相关抗体:
In Vivo	CyPep-1 (瘤内注射；1200 µg；单剂量) 在乳腺癌小鼠模型中具有抗肿瘤的作用[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
CAS	1319804-91-5
Sequence	Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Lys-Thr-Leu-Arg-Val-Ala-Lys-Ala-Ile-Tyr-Lys-Arg-Tyr-Ile-Glu
Shortening	YGRKKRRQRRRGKTLRVAKAIYKRYIE
Formula	C152H265N57O35
Molar Mass	3451.09
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Szczepanski C, et al. Identification of a novel lytic peptide for the treatment of solid tumours. Genes Cancer. 2014 May;5(5-6):186-200.

PeptideDB